Literature DB >> 12499478

Congenital myasthenic syndrome caused by low-expressor fast-channel AChR delta subunit mutation.

X-M Shen1, K Ohno, T Fukudome, A Tsujino, J M Brengman, D C De Vivo, R J Packer, A G Engel.   

Abstract

OBJECTIVE: To determine the molecular basis of a disabling congenital myasthenic syndrome (CMS) observed in two related and one unrelated Arab kinship.
BACKGROUND: CMS can arise from defects in presynaptic, synaptic basal lamina-associated, or postsynaptic proteins. Most CMS are postsynaptic, and most reside in the AChR epsilon subunit; only two mutations have been reported in the AChR delta subunit to date.
METHODS: Cytochemistry, electron microscopy, alpha-bungarotoxin binding studies, microelectrode and patch-clamp recordings, mutation analysis, mutagenesis, and expression studies in human embryonic kidney cells were employed.
RESULTS: Endplate studies showed AChR deficiency, fast decaying, low-amplitude endplate currents, and abnormally brief channel opening events. Mutation analysis revealed a novel homozygous missense mutation (deltaP250Q) of the penultimate proline in the first transmembrane domain (TMD1) of the AChR delta subunit. Expression studies indicate that deltaP250Q (1) hinders delta/alpha subunit association during early AChR assembly; (2) hinders opening of the doubly occupied closed receptor (A(2)R); and (3) speeds the dissociation of acetylcholine from A(2)R. Mutagenesis studies indicate that deltaP250L also has fast-channel effects, whereas epsilon P245L and epsilon P245Q, identical mutations of the corresponding proline in the epsilon subunit, have mild slow-channel effects.
CONCLUSIONS: deltaP250Q represents the third mutation observed in the AChR delta subunit. The severe phenotype caused by deltaP250Q is attributed to endplate AChR deficiency, fast decay of the synaptic response, and lack of compensatory factors. That the penultimate prolines in TMD1 of the delta and epsilon subunits exert a reciprocal regulatory effect on the length of the channel opening bursts reveals an unexpected functional asymmetry between the two subunits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499478     DOI: 10.1212/01.wnl.0000042422.87384.2f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.

Authors:  Akio Masuda; Xin-Ming Shen; Mikako Ito; Tohru Matsuura; Andrew G Engel; Kinji Ohno
Journal:  Hum Mol Genet       Date:  2008-09-20       Impact factor: 6.150

2.  A novel fast-channel myasthenia caused by mutation in β subunit of AChR reveals subunit-specific contribution of the intracellular M1-M2 linker to channel gating.

Authors:  Xin-Ming Shen; Li Di; Shelley Shen; Yuying Zhao; Ann M Neumeyer; Duygu Selcen; Steven M Sine; Andrew G Engel
Journal:  Exp Neurol       Date:  2020-06-03       Impact factor: 5.330

3.  Investigation of Congenital Myasthenia Reveals Functional Asymmetry of Invariant Acetylcholine Receptor (AChR) Cys-loop Aspartates.

Authors:  Xin-Ming Shen; Joan Brengman; David Neubauer; Steven M Sine; Andrew G Engel
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

Review 4.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

5.  Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating.

Authors:  Xin-Ming Shen; Tatsuya Okuno; Margherita Milone; Kenji Otsuka; Koji Takahashi; Hirofumi Komaki; Elizabeth Giles; Kinji Ohno; Andrew G Engel
Journal:  Hum Mutat       Date:  2016-08-21       Impact factor: 4.878

6.  Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders.

Authors:  Anne Michalk; Sigmar Stricker; Jutta Becker; Rosemarie Rupps; Tapio Pantzar; Jan Miertus; Giovanni Botta; Valeria G Naretto; Catrin Janetzki; Nausheen Yaqoob; Claus-Eric Ott; Dominik Seelow; Dagmar Wieczorek; Britta Fiebig; Brunhilde Wirth; Markus Hoopmann; Marisa Walther; Friederike Körber; Markus Blankenburg; Stefan Mundlos; Raoul Heller; Katrin Hoffmann
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

Review 7.  Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions.

Authors:  Sophie Nicole; Yoshiteru Azuma; Stéphanie Bauché; Bruno Eymard; Hanns Lochmüller; Clarke Slater
Journal:  J Neuromuscul Dis       Date:  2017

8.  Slow-channel myasthenia due to novel mutation in M2 domain of AChR delta subunit.

Authors:  Xin-Ming Shen; Margherita Milone; Hang-Long Wang; Brenda Banwell; Duygu Selcen; Steven M Sine; Andrew G Engel
Journal:  Ann Clin Transl Neurol       Date:  2019-09-27       Impact factor: 4.511

9.  Nicotinic acetylcholine receptor subunit variants are associated with blood pressure; findings in the Old Order Amish and replication in the Framingham Heart Study.

Authors:  Patrick F McArdle; Sue Rutherford; Braxton D Mitchell; Coleen M Damcott; Ying Wang; Vasan Ramachandran; Sandy Ott; Yen-Pei C Chang; Daniel Levy; Nanette Steinle
Journal:  BMC Med Genet       Date:  2008-07-14       Impact factor: 2.103

10.  Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth.

Authors:  Emily J Todd; Kyle S Yau; Royston Ong; Jennie Slee; George McGillivray; Christopher P Barnett; Goknur Haliloglu; Beril Talim; Zuhal Akcoren; Ariana Kariminejad; Anita Cairns; Nigel F Clarke; Mary-Louise Freckmann; Norma B Romero; Denise Williams; Caroline A Sewry; Alison Colley; Monique M Ryan; Cathy Kiraly-Borri; Padma Sivadorai; Richard J N Allcock; David Beeson; Susan Maxwell; Mark R Davis; Nigel G Laing; Gianina Ravenscroft
Journal:  Orphanet J Rare Dis       Date:  2015-11-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.